Bazedoxifene, a Postmenopausal Drug, Acts as an Antimalarial and Inhibits Hemozoin Formation-Reference-Cited by-同舟云学术

Bazedoxifene, a Postmenopausal Drug, Acts as an Antimalarial and Inhibits Hemozoin Formation

Published:2022-06-29 Issue:3 Volume:10 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Sudhakar Renu¹,Adhikari Navin¹,Pamnani Saniya¹,Panda Abhipsa¹,Bhattacharjee Manish¹,Rizvi Zeba¹,Shehzad Sadaf²,Gupta Dinesh²^ORCID,Sijwali Puran Singh¹³^ORCID

Affiliation:

1. CSIR-Centre for Cellular and Molecular Biology, Hyderabad, Telangana, India

2. International Centre for Genetic Engineering and Biotechnology, New Delhi, Delhi, India

3. Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh, India

Abstract

The emergence and spread of drug-resistant strains of the human malaria parasite Plasmodium falciparum has necessitated new drugs. Selective estrogen receptor modulators are in clinical use for the prevention and treatment of breast cancer and postmenopausal osteoporosis.

Funder

Council of Scientific and Industrial Research, India

Department of Biotechnology, Ministry of Science and Technology, India

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.02781-21

Reference74 articles.

1. World Health Organization. 2020. World malaria report 2020. https://www.who.int/publications/i/item/9789240015791. Accessed 20 November 2021.

2. MalDA, Accelerating Malaria Drug Discovery